Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (2)

P 4 (1)

Trial Status

Recruiting2

Completed1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials

NCT07841691Not ApplicableRecruiting

Optimising Antibiotic Use for Paediatric Lower Respiratory Tract Infections in Africa

NCT06542120Recruiting

Research on Body Voice AI Recognition System for Children's Health Management

NCT06211985Not ApplicableCompleted

Copeptin: Disease Severity Indicator

NCT01492387Phase 4Unknown

Duration of Antibiotic Therapy in Community - Acquired Pneumonia

Showing all 4 trials

Bronchopneumonia